Navigation Links
New cell transplantation journal launched
Date:8/30/2010

Tampa, Fla. (August 30, 2010) A new and unique journal on cell transplantation aimed at helping translate laboratory findings into clinical applications is being launched by Cognizant Communication Corporation (www.cognizantcommunication.com) as a companion journal to Cell Transplantation. Cell Medicine, an online-only, open access journal, publishes research papers that promise to have direct clinical relevance. The journal is freely accessible at: http://www.ingentaconnect.com/content/cog/cm.

"This journal will offer critical evaluation of cell medicine as a safe and effective treatment for human disorders, many of which are debilitating and many times fatal," said Dr. Paul Sanberg, executive editor of the new journal and director of the University of South Florida's Center of Excellence in Aging and Brain Repair.

According to Dr. Sanberg, the list of new stem cell sources is growing to include those derived from the embryo; fetus; umbilical cord; placenta; amniotic fluid; bone marrow; fat cells; skin; and menstrual blood, among others. Acquiring a patient-specific set of stem cells is a key to the success of cell medicine, he said. In addition, the international focus of the journal originates from the many translational studies of cell transplantation occurring around the world.

Cell Medicine has a widely diverse and global editorial board drawn from academia, the biomedical industry and regulatory agencies - experts engaged in the science and translation of a cell product as it emerges from the laboratory and makes its way into clinical practice. The journal fills a public information gap as many of the findings of biomedical companies are published in in-house publications, as are guidelines and other information generated by regulatory agencies. Once more, there has been a desire on the part of researchers to be able to publish findings that they present at meetings and the journal addresses that need.

"Our goal is to not only promote translational research, but also, after fair and rapid peer review, to publish those papers on cell therapy with direct clinical relevance," concluded Dr. Sanberg.

Papers appearing in the inaugural issue of Cell Medicine highlight the international nature of the work published in Cell Medicine and they include:

  • "Cell Therapy from Bench to Bedside Translation in the CNS Neurorestoratology Era." (Huang et al; China/USA)
  • "New Strategies for Acute Liver-Failure: Focus on Xenotransplantation Therapy," (Alves et al; Brazil)
  • "Purification and Characterization of Adipose-derived Stem Cells from Patients with Lipoaspirate Transplant" (Folgeiro et al; Italy)
  • "Liver Cell Culture Devices" (Andria et al; Italy/Netherlands)


'/>"/>

Contact: David Eve
cellmedicinect@gmail.com
Cell Transplantation Center of Excellence for Aging and Brain Repair
Source:Eurekalert

Related biology news :

1. Ovarian transplantation restores fertility to old mice and also lengthens their lives
2. Coral transplantation the simple and cheap solution to reef restoration
3. Cell Transplantation reports consistent and successful islet isolations offer diabetes hope
4. Novel Parkinsons treatment strategy involves cell transplantation
5. Rare genetic disease successfully reversed using stem cell transplantation
6. Ovarian transplantation: First baby is born after a new technique
7. Ovarian transplantation: New technique gives greatly improved results in this delicate operation
8. REGiMMUNE presents enhanced efficacy data in preclinical transplantation models
9. New book includes advances in the science and practice of transfusion and transplantation
10. Tips from the journals of the American Society for Microbiology
11. Are there too many stem cell journals?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... Report Highlights ... The global synthetic-biology market reached nearly $3.9 ... growing at a compound annual growth rate (CAGR) of 24.0% ... global markets for synthetic biology. - Analyses of global market ... of compound annual growth rates (CAGRs) through 2021. - Coverage ...
(Date:2/7/2017)... Ind. , Feb. 7, 2017 Zimmer ... leader in musculoskeletal healthcare, will present at the LEERINK ... New York Palace Hotel on Wednesday, February 15, 2017 ... live webcast of the presentation can be accessed at ... replay following the conference via Zimmer Biomet,s Investor Relations ...
(Date:2/3/2017)... 2017 A new independent identity strategy consultancy ... (IdSP) . Designed to fill a critical niche in ... founding partners Mark Crego and Janice ... in identity expertise that span federal governments, the 9/11 ... Crego-Kephart combined expertise has a common theme born from ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... ANGELES , Feb. 16, 2017   ... ), a clinical-stage biotechnology company developing first-in-class biological ... announced that it has elected to terminate its ... natriuretic peptide receptor agonists, including Cenderitide. ... strategic move as we prioritize our efforts to ...
(Date:2/16/2017)...  Champions Oncology, Inc. (NASDAQ: CSBR ), ... advanced technology solutions and products to personalize the development ... of new cohorts of PDX models to their existing ... Champions, product line in hepatocellular cancer, breast cancer, castrate ... non-small cell lung cancer (including EGFR mutation; ALK/ROS1 positive) ...
(Date:2/16/2017)... ... February 16, 2017 , ... ... Research Inc. has further extended its industry leading Biochemistry Services specifically targeting ... state-of-the-art cGMP techniques and methods for the biochemical and biosimilar characterization ...
(Date:2/15/2017)... WASHINGTON, Feb. 15, 2017  Vanda Pharmaceuticals Inc. ... results for the fourth quarter and full year ... an exceptional year for Vanda as we continued ... and secured long-term exclusivity for Fanapt," said Mihael ... addition, our emerging pipeline with important 2017 milestones ...
Breaking Biology Technology: